Merck launches their Merck Foundation in Niger in partnership with the First Lady of Niger and their Ministry of Health. During the launch event Merck Foundation, marks ‘International women’s Day’ in Niger to empower infertile women through “Merck More Than a Mother” campaign.
Merck Foundation met the president of Niger H.E. Mahamadou Issoufou to discuss and underscore our long-term commitment to healthcare capacity building, and empowering women and youth in Niger through our impactful programs; Merck Cancer Access Program and Merck More Than a Mother in partnership with the First Lady of Niger H.E. Mrs. Aissata Issoufou Mahamadou
During the event, Prof. Frank Stangenberg-Haverkamp, Chairman of the Executive Board of E.Merck KG and the Chairman of Merck Foundation Board of Trustees emphasized, " We are very proud to launch our Merck Foundation in partnership with the First Lady of Niger and Ministry of Health to build healthcare capacity, improve access to Cancer and Diabetes care and to empower infertile women in the country."
(L-R) Hon. Dr. Idi Illiassou Mainassara, Minister of Public Health for Niger, Prof. Frank Stangenberg-Haverkamp, Chairman of the Executive Board of E.Merck KG and the Chairman of Merck Foundation Board of Trustees and Dr. Rasha Kelej, the CEO of Merck Foundation discussing Merck Foundation's long-term commitment to building healthcare capacity in Niger
Dr. Rasha Kelej CEO of Merck Foundation explained, “We are very proud to appoint H.E. Mrs. Aissata Issoufou Mahamadou, the First Lady of The Republic of Niger, as an ambassador of ‘Merck More Than a Mother’ campaign, to work closely with Merck Foundation in defining interventions to break the stigma around childless women across the country. Through our partnership, we will transform the lives of those unprivileged women, women who suffered all their lives from the Infertility stigma.”
Merck foundation appointed the First Lady of Niger H.E. Mrs. Aissata Issoufou Mahamadou as an Ambassador of 'Merck More Than a Mother'
Her Excellency, the First Lady of Niger, H.E. Mrs. Aissata Issoufou Mahamadou emphasized, “I truly value our partnership with Merck Foundation. I firmly believe that building professional capacity is a good strategy to help our government to improve access to healthcare in our country. I will also work closely with Merck foundation to break the stigma around infertility at all levels by raising awareness, training the skills of local experts and by supporting childless women in starting their small businesses.”
(L-R) Dr. Rasha Kelej, the CEO of Merck Foundation, Prof. Frank Stangenberg-Haverkamp, Chairman of the Executive Board of E.Merck KG and the Chairman of Merck Foundation Board of Trustees discussed long-term commitment to healthcare capacity building with the President of Niger H.E. Mahamadou Issoufou
“As per the information received from the Ministry of Health, for 22 Million population Niger has only six oncologists, one hematologist, and 12 radiotherapists. This gap is of course not enough to give proper access to quality and equitable cancer care across the country. We hope we can significantly increase the number of oncologists in the next three years.” Rasha Kelej added.
Merck Foundation is committed to providing one-year to two-years Oncology Fellowship Programs and Clinical Fertility Management Training to four candidates from Niger in 2018 and is determined to provide training to more candidates in the future.
Moreover, Merck Foundation is committed to contributing toward advancing Diabetes Care in Niger, by providing online Diabetes Management Diploma in the French language, for medical postgraduates in Niger and other Francophone African countries, so that they can learn more about diagnosis and treatment of diabetes. The course is accredited by 'Royal college for general practitioners' in the UK.
About Merck Foundation in Niger:
Merck Foundation is going to provide the oncology and clinical fertility training to the following healthcare professional from Niger:
1. Dr. Mamadou Oumarou ramatou- Adult medical oncology
2. Dr. Mahamadou Aichatou- Paediatric Oncology
3. Dr. Alhousseini Alhassane laila- Radiation oncology
4. Dr. Moussa Soffo Issa- Radiation technician
Clinical Fertility Management Training
1. Dr. Abdoulaye Maiga
2. Dr. Barkire Fatoumatou
3. Dr. Lawali Chekarao Mamadou.
So far, candidates from Uganda, Zambia, Ethiopia, Namibia, Tanzania, Ghana, Sierra Leone, South Africa, Botswana, Liberia, Rwanda, Kenya, Chad, Niger, Guinea, Gambia, Sri Lanka, Cambodia, Bangladesh, Myanmar, and Nepal have benefitted from Merck Foundation's training programs in fertility or oncology fellowships. Merck Foundation aims to expand to more African and Asian countries soon.
One Click on icon below to
Download Merck Foundation App
The Merck Foundation, established in 2017, is the philanthropic arm of Merck KGaA Germany, aims to improve the health and wellbeing of people and advance their lives through science and technology. Our efforts are primarily focused on improving access to quality & equitable healthcare solutions in underserved communities, building healthcare and scientific research capacity and empowering people in STEM (Science, Technology, Engineering, and Mathematics) with a special focus on women and youth. All Merck Foundation press releases are distributed by e-mail at the same time they become available on the Merck Foundation Website. Please visit www.merck-foundation.com to read more. To know more, reach out to our social media: Merck Foundation; Facebook, Twitter, Instagram, YouTube and Flicker.
Merck is a leading science and technology company in healthcare, life science and performance materials. Almost 52,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions.
Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma.